SCHEMBL452093

SCHEMBL452093

[CH]1C=CC[CH]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL835927 0.79
SCHEMBL1541269 0.75
SCHEMBL1541265 0.75
SCHEMBL1112942 0.75
SCHEMBL1541774 0.75
SCHEMBL1112941 0.75
SCHEMBL1541267 0.75
SCHEMBL25653 0.73
SCHEMBL1113653 0.72
SCHEMBL1540769 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399423-A1 POLYMERIC DISINFECTANTS AND USES THEREOF TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2023-12-14 US disclosed
CN-104937011-B Block copolymers with polydimethylsiloxane blocks 巴斯夫欧洲公司 2020-12-29 CN disclosed
EP-3452465-B1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES GENOSCIENCE PHARMA (FR) 2020-11-04 EP disclosed
US-10577362-B2 Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases GENOSCIENCE PHARMA (FR) 2020-03-03 US disclosed
US-10301434-B2 Block copolymers having a polydimethylsiloxane block BASF SE (DE) 2019-05-28 US disclosed
US-20190144437-A1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES GENOSCIENCE PHARMA (FR) 2019-05-16 US disclosed
EP-3452465-A1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES Genoscience Pharma SAS (FR) 2019-03-13 EP disclosed
WO-2017191599-A1 SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES GENOSCIENCE PHARMA (FR) 2017-11-09 WO disclosed
EP-2945976-B1 BLOCK COPOLYMERS HAVING A POLYDIMETHYLSILOXANE BLOCK BASF SE (DE) 2016-12-21 EP disclosed
US-20160326153-A1 N-SUBSTITUTED IMINO HETEROCYCLIC COMPOUNDS BASF SE (DE) 2016-11-10 US disclosed
EP-1715862-A1 KINASE INHIBITORS Devgen NV (BE) 2006-11-02 EP disclosed
US-20060167134-A1 Resin composition and process for producing resin molding Lerner, David, Littenberg, Krumholz & Mentlik, LLP 2006-07-27 US disclosed
US-20060154912-A1 Isophtalic acid derivatives BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-07-13 US disclosed
EP-1591487-A1 RESIN COMPOSITION AND PROCESS FOR PRODUCING RESIN MOLDING Sony Corporation (JP) 2005-11-02 EP disclosed
EP-1572628-A1 ISOPHTALIC ACID DERIVATIVES Bayer HealthCare AG (DE) 2005-09-14 EP disclosed
WO-2005082367-A1 KINASE INHIBITORS DEVGEN NV (BE) 2005-09-09 WO disclosed
EP-1538184-A1 RESIN COMPOSITION Sony Corporation (JP) 2005-06-08 EP disclosed
US-20050014870-A1 Resin composition SONY CORPORATION (JP) 2005-01-20 US disclosed
WO-2004052839-A1 ISOPHTALIC ACID DERIVATIVES BAYER HEALTHCARE AG (DE) 2004-06-24 WO disclosed
US-4079038-A HAVING RECURRING DIOXYCARBON MOIETIES ALZA CORPORATION (US) 1978-03-14 US disclosed